AMYLIN PHARMACEUTICALS for AMYLIN PHARMACEUTICALS
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Prevention, diagnosis and treatment of diabetes Diabetes issues related to implementation of provisions of Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG BURTON | — |
| WILLIAM A FRANCO | — |
Medicare/Medicaid MMM
Provisions related to the expansion of Medicaid rebates in Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010) Provisions related to the expansion of Medicaid eligibility in Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010) Provisions related to Medicare Part D rebates Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010) Medicare and Medicaid provisions of H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG BURTON | — |
| WILLIAM A FRANCO | — |
Copyright/Patent/Trademark CPT
Exclusivity, damages,estoppel, post grant review and inter partes review provisions in the America Invents Act (S. 23, H.R. 1249)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG BURTON | — |
| WILLIAM A FRANCO | — |
Medical/Disease Research/Clinical Labs MED
Provisions related to comparative effectiveness research in HR 3590 Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010)
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG BURTON | — |
| WILLIAM A FRANCO | — |
Pharmacy PHA
Perscription Drug User Fee Act reauthorization FDA funding and agency effectiveness Drug importation issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG BURTON | — |
| WILLIAM A FRANCO | — |
Budget/Appropriations BUD
FDA funding and agency effectiveness
| Lobbyist | Covered position, as disclosed |
|---|---|
| CRAIG BURTON | — |
| WILLIAM A FRANCO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.